Superstring Capital Management »

Quanterix Ord shares owned by Superstring Capital Management

Quarter-by-quarter ownership of Quanterix Ord (QTRX) shares owned by Superstring Capital Management from 13F filings

Historical chart of Superstring Capital Management investment in Quanterix Ord

Tip: Access up to 7 years of quarterly data

All positions including Quanterix Ord held by Superstring Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quanterix Ord by Superstring Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 72k 27.34

More positions owned by Superstring Capital Management

ImmunoGen
Cytokinetics Com New (CYTK)
89bio (ETNB)
Ionis Pharmaceuticals (IONS)
Ideaya Biosciences (IDYA)
Protagonist Therapeutics (PTGX)
Immunovant (IMVT)
Bridgebio Pharma (BBIO)
Day One Biopharmaceuticals I (DAWN)
Marinus Pharmaceuticals Com New (MRNS)
Neurocrine Biosciences (NBIX)
Urogen Pharma (URGN)
Savara (SVRA)
Roivant Sciences SHS (ROIV)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)

View all positions for Superstring Capital Management

Top funds holding Quanterix Ord

Millennium Management
Vanguard Group
Lord, Abbett & Co
Portolan Capital Management
Gilder, Gagnon, Howe & Co
Dimensional Fund Advisors
Ashford Capital Management
Baillie Gifford & Co
D. E. Shaw & Co
Emerald Advisers
Boone Capital Management
Alliancebernstein
Emerald Mutual Fund Advisers, Trust
Charles Schwab Investment Management
Adviser Investments

View all funds holding Quanterix Ord